Brenda Elena Varela
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Brenda Elena Varela has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
Anabella Arce
Hospital Alemán, Ciudad Autónoma Buenos Aires, Argentina
1 shared publicationCarlos Alberto Nigro
Hospital Alemán, Ciudad Autónoma Buenos Aires, Argentina
1 shared publicationDavid Smith
Hospital Italiano, Ciudad Autónoma Buenos Aires, Argentina
1 shared publicationGabriela Claudia Tabaj
Hospital A. Cetrángolo, Ciudad Autónoma Buenos Aires, Argentina
1 shared publicationGabriela Tabaj
Hospital Cetrángolo, Buenos Aires, Argentina
1 shared publication- Gabriela Tabaj
Hospital Cetrangolo, Florida, Argentina
1 shared publication
Latest Publications
- 17 October 2026
- Published by Springer Nature in Rheumatology International
- Vol. 46 (11) , 291
Divergent approaches to rheumatoid arthritis–associated interstitial lung disease: a comparative analysis of international clinical practice guidelines
Rheumatoid arthritis–associated interstitial lung disease (RA-ILD) is associated with substantial morbidity and mortality. We compared international and regional clinical practice guidelines to identify agreement, differences, and gaps in RA-ILD care. We conducted a narrative comparative review of five guideline groups: ERS/EULAR, ACR/CHEST, EULAR, PANLAR, and ALAT. Recommendations were assessed across screening, diagnosis, monitoring, and treatment, together with their methodological approaches. Diagnostic recommendations showed the greatest agreement: ILD-focused guidelines emphasized high-resolution computed tomography (HRCT), pulmonary function tests, and multidisciplinary evaluation. Screening recommendations differed: ERS/EULAR and ACR/CHEST favored risk-based assessment, whereas ALAT proposed a broader approach that included lung ultrasound as an adjunct, without replacing HRCT. For established RA-ILD, ACR/CHEST suggested, as implementation guidance, pulmonary function testing every 3–12 months during the first year and HRCT when clinically indicated; ERS/EULAR proposed pulmonary function testing every 3–6 months in the first years and periodic HRCT. Treatment showed the greatest divergence. ACR/CHEST conditionally recommended mycophenolate, rituximab, azathioprine, and cyclophosphamide as first-line ILD therapies, whereas ALAT emphasized integrated control of articular and pulmonary disease, particularly with abatacept or rituximab. EULAR and PANLAR primarily addressed RA treatment and did not provide dedicated RA-ILD algorithms. Antifibrotic treatment was considered mainly in progressive fibrosing disease. Guidelines converge on HRCT-based evaluation but differ in screening, monitoring intervals, and treatment priorities. These differences reflect their scope, methodology, and limited RA-ILD-specific evidence. Prospective comparative studies are needed to inform more consistent care.
- 17 October 2026
- Published by Springer Nature in Rheumatology International
- Vol. 46 (11) , 291
Divergent approaches to rheumatoid arthritis–associated interstitial lung disease: a comparative analysis of international clinical practice guidelines
Rheumatoid arthritis–associated interstitial lung disease (RA-ILD) is associated with substantial morbidity and mortality. We compared international and regional clinical practice guidelines to identify agreement, differences, and gaps in RA-ILD care. We conducted a narrative comparative review of five guideline groups: ERS/EULAR, ACR/CHEST, EULAR, PANLAR, and ALAT. Recommendations were assessed across screening, diagnosis, monitoring, and treatment, together with their methodological approaches. Diagnostic recommendations showed the greatest agreement: ILD-focused guidelines emphasized high-resolution computed tomography (HRCT), pulmonary function tests, and multidisciplinary evaluation. Screening recommendations differed: ERS/EULAR and ACR/CHEST favored risk-based assessment, whereas ALAT proposed a broader approach that included lung ultrasound as an adjunct, without replacing HRCT. For established RA-ILD, ACR/CHEST suggested, as implementation guidance, pulmonary function testing every 3–12 months during the first year and HRCT when clinically indicated; ERS/EULAR proposed pulmonary function testing every 3–6 months in the first years and periodic HRCT. Treatment showed the greatest divergence. ACR/CHEST conditionally recommended mycophenolate, rituximab, azathioprine, and cyclophosphamide as first-line ILD therapies, whereas ALAT emphasized integrated control of articular and pulmonary disease, particularly with abatacept or rituximab. EULAR and PANLAR primarily addressed RA treatment and did not provide dedicated RA-ILD algorithms. Antifibrotic treatment was considered mainly in progressive fibrosing disease. Guidelines converge on HRCT-based evaluation but differ in screening, monitoring intervals, and treatment priorities. These differences reflect their scope, methodology, and limited RA-ILD-specific evidence. Prospective comparative studies are needed to inform more consistent care.
- 14 September 2024
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 64 (suppl 68) , PA5157
Comparison of ILD at risk of PH between transplant center and referral care settings
Introduction: Pulmonary hypertension (PH) screening is recommended for lung transplant candidates, differing from referral centers where suspicion drives evaluation. This study aims to compare population characteristics and factors associated with PH in both populations. Methodology: This cross-sectional study compares subjects with interstitial lung disease (ILD) from referral centers (RC) undergoing usual care PH assessment and those assessed during pre-transplant evaluation (TC). Univariate and multivariate logistic regression models were employed to evaluate PH risk in both groups. Results: We included 128 patients from RC and 77 from TC. Comparing PH-ILD: TC group mean age 57.9 vs. RC group 68.9 years, FVC (%) 50.06±14.27 vs. 66±16, mean DLco (%) 34.76±13.95 vs. 38±18, mean 6MWT distance 219±129 vs. 303±124 meters, and PA diameter on CT scan 31.4±4.15 vs. 33±6 mm respectively. Mean pulmonary pressure by right heart catheterization was 26.8 vs. 35.5 mmHg. Multivariate analysis in RC group revealed increased PH risk with lower DLCO (OR 0.33 p=0.089), higher BORG score post-6MWT (OR 1.7 p=0.022), and higher PA diameter (OR 1.4 p=0.001). In TC group, higher FVC (OR 1.08, p=0.042), shorter 6MWT distance (OR 0.99, p=0.014), and higher PA diameter (OR 1.43, p=0.005) were associated with higher PH risk. Conclusions: In TC group, PH was linked to higher FVC, shorter 6MWT distance, and larger PA diameter on CT, contrasting lower FVC, DLco, shorter 6MWT distance, and milder PH in RHC, where RC group exhibited more severe PH. These differences and similarities in PH-associated factors should inform risk assessment in both populations.
- 14 September 2024
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 64 (suppl 68) , PA5157
Comparison of ILD at risk of PH between transplant center and referral care settings
Introduction: Pulmonary hypertension (PH) screening is recommended for lung transplant candidates, differing from referral centers where suspicion drives evaluation. This study aims to compare population characteristics and factors associated with PH in both populations. Methodology: This cross-sectional study compares subjects with interstitial lung disease (ILD) from referral centers (RC) undergoing usual care PH assessment and those assessed during pre-transplant evaluation (TC). Univariate and multivariate logistic regression models were employed to evaluate PH risk in both groups. Results: We included 128 patients from RC and 77 from TC. Comparing PH-ILD: TC group mean age 57.9 vs. RC group 68.9 years, FVC (%) 50.06±14.27 vs. 66±16, mean DLco (%) 34.76±13.95 vs. 38±18, mean 6MWT distance 219±129 vs. 303±124 meters, and PA diameter on CT scan 31.4±4.15 vs. 33±6 mm respectively. Mean pulmonary pressure by right heart catheterization was 26.8 vs. 35.5 mmHg. Multivariate analysis in RC group revealed increased PH risk with lower DLCO (OR 0.33 p=0.089), higher BORG score post-6MWT (OR 1.7 p=0.022), and higher PA diameter (OR 1.4 p=0.001). In TC group, higher FVC (OR 1.08, p=0.042), shorter 6MWT distance (OR 0.99, p=0.014), and higher PA diameter (OR 1.43, p=0.005) were associated with higher PH risk. Conclusions: In TC group, PH was linked to higher FVC, shorter 6MWT distance, and larger PA diameter on CT, contrasting lower FVC, DLco, shorter 6MWT distance, and milder PH in RHC, where RC group exhibited more severe PH. These differences and similarities in PH-associated factors should inform risk assessment in both populations.
- 5 September 2021
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 58 (suppl 65) , PA402
Agreement in the evaluation of interstitial lung diseases between multiples observers and a mobile app in Argentina
Introduction: The EPIDIA App is an application for mobile devices (App) to assist physicians in the care of Interstitial Lung Diseases (ILD) patients. Primary objective: To evaluate the agreement in the diagnosis of ILD between multiples observers vs EPIDIA in Argentina. Methods: Patients with diagnosis of ILD were analyzed retrospectively. The clinical cases were reviewed by 5 pulmonologists (4 of them with 5 to 10 years of experience in the management of patients with ILD, and the last one with more than 20 years of experience in the management of these patients) and EPIDIA app. Relevant clinical and laboratory data, including autoantibodies, bronchoalveolar lavage, transbronchial biopsy, lung function and high resolution computed tomography (HRCT) were evaluated in each case. The interobserver agreement was evaluated analyzing the final diagnosis of each observer. Descriptive analysis was performed. The kappa was calculated for multiple observers. Results: Twenty patients with diagnosis of ILD were evaluated. The mean age was 63 ± 11.75 years old. 70% were current or former smokers. The mean forced vital capacity (FVC) was 2.86± 0.77 L in absolute values and 73% ± 11.85, and the mean DLCO was 58% ± 18.31. Regarding the final diagnosis, the agreement was 0.73 (CI 95%: 0.66-0.89), with a good degree of agreement in the diagnosis of the collagen tissue diseases (CTD-ILD) 0.84 (CI 95% 0.67-1.00), moderate in idiopathic pulmonary fibrosis (IPF) 0.64 (CI 95%: 0.47-0.73) and weak in possible UIP 0.20 (CI 95%: 0.015-051). Conclusions: The overall agreement in the final diagnosis was good. EPIDIA might be a useful too, specially for those physicians who have no access to MDD.
- 5 September 2021
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 58 (suppl 65) , PA402
Agreement in the evaluation of interstitial lung diseases between multiples observers and a mobile app in Argentina
Introduction: The EPIDIA App is an application for mobile devices (App) to assist physicians in the care of Interstitial Lung Diseases (ILD) patients. Primary objective: To evaluate the agreement in the diagnosis of ILD between multiples observers vs EPIDIA in Argentina. Methods: Patients with diagnosis of ILD were analyzed retrospectively. The clinical cases were reviewed by 5 pulmonologists (4 of them with 5 to 10 years of experience in the management of patients with ILD, and the last one with more than 20 years of experience in the management of these patients) and EPIDIA app. Relevant clinical and laboratory data, including autoantibodies, bronchoalveolar lavage, transbronchial biopsy, lung function and high resolution computed tomography (HRCT) were evaluated in each case. The interobserver agreement was evaluated analyzing the final diagnosis of each observer. Descriptive analysis was performed. The kappa was calculated for multiple observers. Results: Twenty patients with diagnosis of ILD were evaluated. The mean age was 63 ± 11.75 years old. 70% were current or former smokers. The mean forced vital capacity (FVC) was 2.86± 0.77 L in absolute values and 73% ± 11.85, and the mean DLCO was 58% ± 18.31. Regarding the final diagnosis, the agreement was 0.73 (CI 95%: 0.66-0.89), with a good degree of agreement in the diagnosis of the collagen tissue diseases (CTD-ILD) 0.84 (CI 95% 0.67-1.00), moderate in idiopathic pulmonary fibrosis (IPF) 0.64 (CI 95%: 0.47-0.73) and weak in possible UIP 0.20 (CI 95%: 0.015-051). Conclusions: The overall agreement in the final diagnosis was good. EPIDIA might be a useful too, specially for those physicians who have no access to MDD.
- 7 September 2020
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 56 (suppl 64)
Agreement between different oximetric sensors during exercise in chronic respiratory diseases: a pilot study
Introduction: The oxygen saturation (SO2) can be measured using finger, ear or forehead sensors. The primary objective of this study was to evaluate the degree of agreement in the measurement of SO2 with different sensors (finger, ear and frontal) during six-minute walk test (6MWT) in patients with chronic obstructive pulmonary disease (COPD) and fibrosing interstitial lung diseases (f-ILD). Methodology: Observational and prospective study. SO2 measurements were made simultaneously with 3 sensors (finger-SO2-fg, ear-SO2-e, forehead reflectance-SO2-fh) at baseline, during and after the test (Nonin Wrist-Ox 3150). Result: 31 patients were evaluated (14 COPD, 17 f-ILD). The mean of age was 64.8, 54% women. BMI:24.6. FVC: 75.6%±17, FEV1: 64%±21. DLCO: 60%±20. 6MWT (m):436.9±97.The mean baseline SO2 was: SO2-fg 94.2% ± SD 1.96 (91-98%), SO2-fh 98.2% SD ± 1.82 (93%-100%) and SO2-e 98.2% ± SD 1.97 (93%-100%). The mean final SO2 was: SO2-fg86% ± SD 7.91 (69%-97%), SO2-fh 92% ± SD 8.87 (65%-100%) and SO2.e 91.8% ± SD 8.57 (67%-100%), The percentage of patients with O2 desaturation according to the type of sensor was: SO2-fg 74%, SO2-fh 61% and SO2-e 55%.The mean baseline SO2 difference between the sensors were: fg vs fh was -4.03% (95% CI: -4.62 to -3.43), fg vs e -3.96% (95% CI -4.64 to -3.29) and fh vs e -0.065 % (95% CI -0.39 to 0.52). The mean final SO2 difference between the fg vs fh was – 6.03% (95% CI -7.89 to -4.17), fg vs e -5.80% (95% CI -7.29 to -4.31), fh vs e -0.22 (95% CI -0.60 to -4.77). Conclusions: The fh/e sensors had SO2 readings had greater than the fg (baseline and at minute 6). A low degree of agreement was observed between the fg vs fh/e sensors.
- 7 September 2020
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 56 (suppl 64)
Agreement between different oximetric sensors during exercise in chronic respiratory diseases: a pilot study
Introduction: The oxygen saturation (SO2) can be measured using finger, ear or forehead sensors. The primary objective of this study was to evaluate the degree of agreement in the measurement of SO2 with different sensors (finger, ear and frontal) during six-minute walk test (6MWT) in patients with chronic obstructive pulmonary disease (COPD) and fibrosing interstitial lung diseases (f-ILD). Methodology: Observational and prospective study. SO2 measurements were made simultaneously with 3 sensors (finger-SO2-fg, ear-SO2-e, forehead reflectance-SO2-fh) at baseline, during and after the test (Nonin Wrist-Ox 3150). Result: 31 patients were evaluated (14 COPD, 17 f-ILD). The mean of age was 64.8, 54% women. BMI:24.6. FVC: 75.6%±17, FEV1: 64%±21. DLCO: 60%±20. 6MWT (m):436.9±97.The mean baseline SO2 was: SO2-fg 94.2% ± SD 1.96 (91-98%), SO2-fh 98.2% SD ± 1.82 (93%-100%) and SO2-e 98.2% ± SD 1.97 (93%-100%). The mean final SO2 was: SO2-fg86% ± SD 7.91 (69%-97%), SO2-fh 92% ± SD 8.87 (65%-100%) and SO2.e 91.8% ± SD 8.57 (67%-100%), The percentage of patients with O2 desaturation according to the type of sensor was: SO2-fg 74%, SO2-fh 61% and SO2-e 55%.The mean baseline SO2 difference between the sensors were: fg vs fh was -4.03% (95% CI: -4.62 to -3.43), fg vs e -3.96% (95% CI -4.64 to -3.29) and fh vs e -0.065 % (95% CI -0.39 to 0.52). The mean final SO2 difference between the fg vs fh was – 6.03% (95% CI -7.89 to -4.17), fg vs e -5.80% (95% CI -7.29 to -4.31), fh vs e -0.22 (95% CI -0.60 to -4.77). Conclusions: The fh/e sensors had SO2 readings had greater than the fg (baseline and at minute 6). A low degree of agreement was observed between the fg vs fh/e sensors.